Lim J, Park Y, Ahn JW, Sim J, et al. Autologous adoptive immune-cell therapy elicited a durable response with enhanced immune reaction signatures in patients with recurrent glioblastoma: An open label, phase I/IIa trial. PLoS One 2021;16:e0247293.
PMID: 33690665